dipyridamole has been researched along with Hypogammaglobulinemia in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
McKenzie, PE | 1 |
Taylor, AE | 1 |
Woodroffe, AJ | 1 |
Seymour, AE | 1 |
Chan, YL | 1 |
Clarkson, AR | 1 |
Shah, T | 1 |
Simpson, RJ | 1 |
Webster, AD | 1 |
Peters, TJ | 1 |
2 other studies available for dipyridamole and Hypogammaglobulinemia
Article | Year |
---|---|
Plasmapheresis in glomerulonephritis.
Topics: Adolescent; Adult; Agammaglobulinemia; Anti-Glomerular Basement Membrane Disease; Complement System | 1979 |
Binding of adenosine and receptor-specific analogues to lymphocytes from control subjects and patients with common variable immunodeficiency.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adult; Agammaglobulinemia; Dipyridamole; Erythrocytes; | 1987 |